The Change Reaction in Life Sciences for 2022
Life Sciences companies are looking at a future of personalized medicine in a digital world. This has big implications for clinical trials, R&D and data privacy in the coming year. We can expect a trend toward increasingly strict data stewardship and governance requirements – and greater use of emerging technologies that transform the Life Sciences ecosystem.